iGan Partners
iGan Partners is a Toronto-based, healthcare-focused venture capital firm that provides early-stage capital and operational support to companies commercializing AI-enabled MedTech and digital health technologies. The firm invests at Seed through Series A and provides follow-on funding through to exit, offering smart capital, active support, mentorship, and access to industry and co-investor networks to help portfolio companies scale globally.
Industries
Nr. of Employees
small (1-50)
Portfolio
Provider of high-resolution micro-ultrasound systems (ExactVu); cited in multiple portfolio announcements and press items.
#Medical imaging / MedTech
Developer of the MolecuLight i:X fluorescence wound imaging device; multiple clinical and commercial milestones and financing events reported on the firm site.
#Medical device (wound imaging)
Developer of electronic glasses for low vision; referenced with partnerships, product launches and awards in site posts.
#Assistive vision devices / MedTech
Provider of IoT wearable ultrasound-based monitoring devices; referenced in fundraising and board expansion posts.
#Medical devices (non-invasive hemodynamic monitoring)
iGan led the Seed+ financing to support U.S. expansion, clinical validation and commercial growth (June 5, 2025 announcement).
#Personalized gynecological devices / MedTech
Investment announced May 29, 2025; company develops confidential AI infrastructure for regulated industries.
#Confidential AI infrastructure
Provider of high-resolution micro-ultrasound systems (ExactVu); cited in multiple portfolio announcements and press items.
#Medical imaging / MedTech
Developer of the MolecuLight i:X fluorescence wound imaging device; multiple clinical and commercial milestones and financing events reported on the firm site.
#Medical device (wound imaging)
Developer of electronic glasses for low vision; referenced with partnerships, product launches and awards in site posts.
#Assistive vision devices / MedTech
Provider of IoT wearable ultrasound-based monitoring devices; referenced in fundraising and board expansion posts.
#Medical devices (non-invasive hemodynamic monitoring)
iGan led the Seed+ financing to support U.S. expansion, clinical validation and commercial growth (June 5, 2025 announcement).
#Personalized gynecological devices / MedTech
Investment announced May 29, 2025; company develops confidential AI infrastructure for regulated industries.
#Confidential AI infrastructure